|
|
Volumn 12, Issue 3, 2005, Pages 205-
|
|
Painful lessons
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
IBUPROFEN;
IMATINIB;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
ROFECOXIB;
LACTONE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
SULFONE;
CARDIOVASCULAR RISK;
DRUG APPROVAL;
DRUG INHIBITION;
DRUG MECHANISM;
DRUG MONITORING;
DRUG SAFETY;
DRUG SPECIFICITY;
EDITORIAL;
FEVER;
FOOD AND DRUG ADMINISTRATION;
HEART INFARCTION;
HUMAN;
INFLAMMATION;
OSTEOARTHRITIS;
PAIN;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SMALL INTESTINE DISEASE;
SOCIOECONOMICS;
STOMACH HEMORRHAGE;
STROKE;
DRUG DESIGN;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CYCLOOXYGENASE INHIBITORS;
DRUG DESIGN;
HUMANS;
LACTONES;
PYRAZOLES;
SULFONAMIDES;
SULFONES;
|
|
EID: 33748477106
PISSN: 15459993
EISSN: 15459985
Source Type: Journal
DOI: 10.1038/nsmb0305-205 Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|